JF
GOSS icon

Jump Financial’s Gossamer Bio GOSS Stock Holding History

Jump Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-144,949
Closed -$171K – 1976
2024
Q1 		$171K Buy
+144,949
New +$160K ﹤0.01% 1720
2022
Q4 		– Sell
-27,700
Closed -$332K – 1748
2022
Q3 		$332K Buy
+27,700
New +$344K 0.01% 1096
2022
Q2 		– Sell
-35,500
Closed -$308K – 1774
2022
Q1 		$308K Sell
35,500
-12,568
-26% -$121K 0.01% 1057
2021
Q4 		$544K Buy
+48,068
New +$571K 0.03% 615
2021
Q2 		– Sell
-14,931
Closed -$138K – 1208
2021
Q1 		$138K Buy
+14,931
New +$151K 0.01% 804

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jump Financial's GOSS Position: Q2 2024 in Review

Jump Financial sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 144,949 shares — an estimated $171K sold.

Jump Financial first reported a position in GOSS in Q1 2021 and held it in 5 quarters. The position peaked at $544K in Q4 2021. 94 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

  • Jump Financial reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 144,949 Gossamer Bio shares in Q2 2024, an estimated $171K.
  • Jump Financial first reported a position in Gossamer Bio in Q1 2021 and held it in 5 quarters.
  • Jump Financial's Gossamer Bio position peaked at $544K in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.